Ibrutinib-related atrial fibrillation: Therapeutic challenges
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218785983
Abstract: Ibrutinib is a drug used in several lymphohyperplastic diseases. Its use is associated with an increased risk of atrial fibrillation. New-onset atrial fibrillation in this setting is a true challenge as several antiarrhythmic drugs are… read more here.
Keywords: atrial fibrillation; fibrillation; fibrillation therapeutic; related atrial ... See more keywords
Ibrutinib-related uveitis: A report of two severe cases.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of ophthalmology"
DOI: 10.1177/11206721211001268
Abstract: INTRODUCTION Ibrutinib is a small-molecule drug approved for the treatment of haematological disorders and is known to be associated with visual disturbances, but uveitis has not yet been reported as an adverse effect of this… read more here.
Keywords: ibrutinib; treatment; cases ibrutinib; related uveitis ... See more keywords